Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Studies of Chemopreventive Agents, Workstatement 37-261995037
Fox Chase Cancer Center, Philadelphia, PA, United States
Search grants from Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Birc5 as a regulator of NK cell development and immune function
Intestinal Morphogenesis and Differentiation
Genetic Determinants of Outcomes in Acute Kidney Injury
Clinical Investigation in Tumor Immunotherapy
Globotriaosyl Ceramide (Gb3/CD77) in Burkitt's Lymphoma
Recently added grants:
The Role of PPM1G in Apolipoprotein E Biology and Atherosclerotic Cardiovascular Disease
Novel Role of Sphingolipids in Maintaining Vascular Homeostasis
Beta adrenergic receptor-dependent regulation of leukocytes in acute cardiac injury
Signaling Pathways and Regulators of Calcium Channels in Heart
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095037-004
Application #
6688606
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Publications
Bellacosa, Alfonso; Godwin, Andrew K; Peri, Suraj et al.
(2010)
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations.
Cancer Prev Res (Phila) 3:48-61
Comments
Be the first to comment on this grant